Mariano Sanchez Crespo

Dr. Mariano Sanchez Crespo

orcid

Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1982 in Immunopharmacology
Verified
Journal Article
Closed access
MCMariano Sanchez Crespo
Mariano Sanchez Crespo
FAFernando Alonso
Fernando Alonso
PIPedro Iñarrea
Pedro Iñarrea
VAVicente Alvarez
Vicente Alvarez
JEJesus Egido
Jesus Egido

19 July 2019 in Science
Verified
Journal Article
Closed access
PDF file
SCSahil Chopra
Sahil Chopra
PGPaolo Giovanelli
Paolo Giovanelli
PAPerla Abigail Alvarado-Vazquez
Perla Abigail Alvarado-Vazquez
SASara Alonso
Sara Alonso
MSMinkyung Song
Minkyung Song
JCJuan R. Cubillos-Ruiz
Juan R. Cubillos-Ruiz
A “sUPR” target for pain management?: The unfolded protein response (UPR) is initiated when unfolded or misfolded proteins accumulate in the endoplasmic reticulum. One highly conserved arm of the UPR, the IRE1α–XBP1 signaling pathway, also plays a role in various other UPR-independent processes, including hypoxia, angiogenesis, and inflammation. Chopra et al. report that this pathway additionally regulates the production of two molecules, cyclooxygenase 2 and microsomal prostaglandin E synthase 1, that help mediate inflammation-induced pain (see the Perspective by Avril and Chevet). When elements of the IRE1α–XBP1 signaling pathway were knocked out, pain behaviors were reduced in two different mouse models of pain. Targeting this pathway may result in improved pain management therapies. Science , this issue p. eaau6499 ; see also p. 224

1 February 1985 in Immunopharmacology
Verified
Journal Article
Closed access
PIPedro Iñarrea
Pedro Iñarrea
JGJulian Gomez-Cambronero
Julian Gomez-Cambronero
JPJosé Pascual
José Pascual
MPMaría del Carmen Ponte
María del Carmen Ponte
LHLuis Hernando
Luis Hernando
MCMariano Sanchez Crespo
Mariano Sanchez Crespo

1 May 1989 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
FDF Lopez Diez
F Lopez Diez
MNMarisa Nieto
Marisa Nieto
SFS Fernandez-Gallardo
S Fernandez-Gallardo
MGM A Gijon
M A Gijon
MCMariano Sanchez Crespo
Mariano Sanchez Crespo
The possible involvement of platelet-activating factor (PAF) in the pathogenesis of endotoxemia, was investigated by using a binding assay to patients' platelets, complemented with the extraction and chemical characterization of PAF obtained from patients' platelets. Platelets from 12 human volunteers had 281 +/- 63 freely accessible high affinity binding sites (PAF-receptors) per platelet; whereas this number was of 49 +/- 37 PAF-receptors per platelet, n = 14 samples, P less than 0.01, in a group of 13 patients with positive blood culture. A group of patients with respiratory or cardiovascular disturbances and negative blood culture had 253 +/- 74, accessible receptors per platelet (n = 19 samples from 16 patients, P less than 0.01 as compared to septic patients, which was not significantly different when compared to control individuals). Patients with sepsis possessed significant amounts of PAF associated to their platelets, whereas this mediator could not be isolated from platelets of patients with respiratory or cardiovascular disturbances and negative blood culture, nor from platelets of control individuals. PAF was also assayed in whole blood samples and found at high concentrations in sepsis patients. These data indicate that occupancy of PAF receptors in combination with high amounts of platelet-associated PAF, is a common finding in patients with sepsis.

11 July 2008 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
YBYolanda Bayón
Yolanda Bayón
ATAntonio G. Trinidad
Antonio G. Trinidad
MPMaría L. de la Puerta
María L. de la Puerta
MRMaría del Carmen Rodríguez
María del Carmen Rodríguez
JBJori Bogetz
Jori Bogetz
AAAndrés Alonso
Andrés Alonso
Potassium channel tetramerization domain (KCTD) proteins contain a bric‐a‐brac, tramtrak and broad complex (BTB) domain that is most similar to the tetramerization domain (T1) of voltage‐gated potassium channels. Some BTB‐domain‐containing proteins have been shown recently to participate as substrate‐specific adaptors in multimeric cullin E3 ligase reactions by recruiting proteins for ubiquitination and subsequent degradation by the proteasome. Twenty‐two KCTD proteins have been found in the human genome, but their functions are largely unknown. In this study, we have characterized KCTD5, a new KCTD protein found in the cytosol of cultured cell lines. The expression of KCTD5 was upregulated post‐transcriptionally in peripheral blood lymphocytes stimulated through the T‐cell receptor. KCTD5 interacted specifically with cullin3, bound ubiquitinated proteins, and formed oligomers through its BTB domain. Analysis of the interaction with cullin3 showed that, in addition to the BTB domain, some amino acids in the N‐terminus of KCTD5 are required for binding to cullin3. These findings suggest that KCTD5 is a substrate‐specific adaptor for cullin3‐based E3 ligases.